Abstract Plenary Oral Abstract Session PL1-SN24 Impact of 100% Pathogen Reduction and
7-Day Storage on Platelet Safety and Availability in Fr... John Pitman* 1, Min-Sun Park 2 …

All other oral sessions will take place at the times and rooms noted below at the Orange
County Convention Center. The B Plenary Abstract Session b will be held Sunday, October …

Aims We demonstrated that earlier release of PR PC translates to sooner availability,
equivalent or better shelf-life, and transfusion of fresher PC for patients vs LVDS. Inventory …

NOTE: This information reflects evidence available at time of publication. This information is
specific to Pooled Platelet Psoralen-Treated (PPPT) components, which were fully …

Background Several risk mitigation steps have improved the safety of platelets in regard to
bacterial contamination, but this continues to be a concern today. A Food and Drug …

Cicchetti et al. 1 describe pathogen reduction technologies (PRT) as preventative measures.
PRT is the logical extension of the Precautionary Principle which has been underpinning …

The development of pathogen reduction technologies (PRT) for labile blood components is
a long-pursued goal in transfusion medicine. While PRT for red blood cells and whole blood …

BACKGROUND In March 2016 the US Food and Drug Administration published a draft
guidance to enhance the safety of platelets (PLTs) for transfusion. Options for hospital …

Background Pathogen reduction (PR) technology will be implemented in pooled platelets in
Canada. It is anticipated that PR platelets will be licensed in Canada for a maximum shelf …

On November 29, 2018, experts in the field of infectious diseases, pathogen reduction
technol-ogies (PRTs) and other participants from blood centers, academia, and industry …